FDA Drug Application (202136) for DARUNAVIR by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202136
Product Number001
FormTABLET; ORAL
Dosage75MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDARUNAVIR
Active IngredientDARUNAVIR



Back to FDA Applications sponsored by MYLAN PHARMS INC